IFITM1 and breast neoplasm: Clinical data indicated that IFITM1 was constitutively overexpressed in 36 out of 40 AI-resistant breast tumor samples and it was overexpressed in AI-resistant breast cancer cells approximately 20- to 30-fold at the mRNA and protein level.